Alterity Therapeutics (ASX:ATH) - Webinar Presentation

Company Presentations

by Finance News Network February 02, 2024 04:13 PM


Dr David Stamler - CEO - Alterity Therapeutics (ASX:ATH) is a clinical-stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases.

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?